// App-Quantinova.ai

LBP3 : The Penumbra START Trial: Preliminary Results on the Clinical Impact of Pre-treatment CTA Source Image ASPECTS in Endovascularly-Treated Stroke Patients

Researchers

Presenter

  • Albert J Yoo

Principal Investigators

  • Elad I Levy

  • Qaisar A Shah

  • Ferdinand K Hui

  • Mayank Goyal

  • Basavaraj V Ghodke

  • Ali Shaibani

  • Mark R Harrigan

  • Tudor G Jovin

  • Michael T Madison

  • Zeshan A Chaudhry

  • Frank R Hellinger II

  • Ramon G Gonzalez

  • Leticia Barraza

  • Arani Bose

  • Vance E McCollom

  • David J Fiorella

  • Aquilla S Turk III

  • Tim W Malisch

  • Osama O Zaidat

  • Michael J Alexander

  • Thomas G Devlin

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • University of Pittsburgh Medical Center, Pittsburgh, PA

  • Harborview Medical Center, Seattle, WA

  • Alberta Health Services, Calgary, AB, Canada

  • Northwest Community Hosp, Arlington Heights, IL

  • Mercy Womens Center, Oklahoma City, OK

  • Swedish Med Cntr, Englewood, CO

  • Cleveland Clinic, Cleveland, OH

  • Abington Memorial Hospital, Abington, PA

  • Stony Brook Univ Medcl Ctr, Stonybrook, NY

  • Alexian Brothers Medical Ctr, Elk Grove, IL

  • Forsyth Medical Center, Winston-Salem, NC

  • Florida Hospial, Orlando, FL

  • St. Paul Radiology, St. Paul, MN

  • The Medical College of Wisconsin, Milwaukee, WI

  • Kaleida Health, Buffalo, NY

  • Medcl Univ of South Carolina, Charleston, SC

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Massachusetts General Hospital, Boston, MA

  • Penumbra Inc., Alameda, CA

  • Chattanooga Ctr for Neurologic Res, Chattanooga, TN

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final